Skip to content

Different Treatments in Chronic Pain Patients.

Research of the Different Treatments for Chronic Pain Patients, Their Effectiveness and Associated Predictors, Offered at the Pain Center AZ Sint-Lucas Ghent.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05768477
Acronym
EC_PC_AZSTL
Enrollment
1000
Registered
2023-03-14
Start date
2023-04-06
Completion date
2027-06-30
Last updated
2024-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Nociplastic Pain

Brief summary

The goal of this observational study is to compare different treatment options in a chronic pain population. The main questions it aims to answer are: * What is the effectiveness of the different therapy options in the pain center of Sint-Lucas on outcomes related to pain and disability? * What are predictive factors for the different therapy options in the pain center of Sint-Lucas? Which factors predict improvement in pain related outcomes? Participant data will be gathered as part of their routine care. They can be advised to 4 different treatment options: * Consultations with the pain specialist * Interventions by the pain specialist (infiltrations, denervations) * Baxter therapy * Interdisciplinary treatment Researchers will compare patients with different dominant pain mechanisms to see which treatment are most effective for which dominant pain mechanisms.

Detailed description

The aim of the present study is to describe the natural flow of the chronic pain patients at the pain center AZ Sint-Lucas. Patients will be examined before starting the therapy, and receive standardized questionnaires at several fixed time points (before, during, and after their therapy trajectory). Information about the present dominant pain mechanism will be gathered during the examination. The questionnaires will gather demographic data, information about the present dominant pain mechanism, psychosocial factors, catastrophizing, fear and avoidance, illness perceptions, fatigue and information about therapy success. During the examination, typical signs of a dominant nociplastic pain mechanism will be gathered. By processing the data of the questionnaires and the examination, knowledge about (1) the amount of patients with a dominant nociplastic pain mechanism at intake, (2) the treatment trajectory for a specific diagnosis, and (3) the prediction of the therapy effect and prognosis will be obtained.

Interventions

Interdisciplinary therapy provided by the physiotherapist, psychologist and occupational therapist.

Consultation with the pain specialist, which might entail prescription of medication of vitamins.

PROCEDUREInterventions

Facet injections, nerve denervations, infiltrations, Qutenza, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation

DRUGBaxter therapy

Ketamine or Linisol baxter therapy

Sponsors

University Ghent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults * Chronic pain patients * Dutch speaking, or good understanding

Exclusion criteria

* Adults unable to give consent * Adults who do not understand Dutch

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain intensity from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsNumeric Rating Scale for pain intensity in the past week, ranges from zero to 100, with a higher score indicating a higher pain intensity
Change in Functionality from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsPatient Specific Complaints questionnaire, using a Numeric Rating Scale, ranging from zero to 100, with a higher score indicating a higher amount of functional disability
Change in Quality of Life from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsEuroQol-5D questionnaire
Change in Pain disability from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsPain Disability Index, ranges from zero to 70, with a higher score indicating more pain-related disability
Change in Pain Frequency from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsQuestions

Secondary

MeasureTime frameDescription
Change in Quality of Life from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsEuroQol - 5D, five questions about health range from one to three with a higher score indicating more difficulties. One question about perceived health ranges from zero to 100 with a higher score indicating better health.
Change in Post exertional malaise from baseline until 18 months0 weeks, 4 weeks, 10 weeks, 6 months, 12 months, 18 monthsQuestions based on the criteria for Chronic Fatigue Syndrome.

Countries

Belgium

Contacts

Primary ContactJessica Van Oosterwijck, Professor
jessica.vanoosterwijck@ugent.be+32 9 332 69 19
Backup ContactElise Cnockaert
elise.cnockaert@ugent.be+32 9 332 56 35

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026